Joshua D. Palmer

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

November, 2024

Joshua D. Palmer

Jul 28, 2024, 15:37 | Insight

Joshua D. Palmer: TURBO-NSCLC study looking at TKI alone or combination with SRS for brain metastasis

Joshua D. Palmer, Radiation Oncologist and Associate Professor at The Ohio State University Wexner Medical…

Jul 25, 2024, 21:48 | Insight

Stephen V Liu: What is the role for SRS to brain metastases up front for EGFR or ALK NSCLC?

Stephen V Liu shared a paper by Luke R.G. Pike et al. on X, adding: “What…

Jul 25, 2024, 14:02 | Insight

Erman Akkus: Should up-front SRS be added to TKI in brain metastatic EGFR/ALK positive NSCLC?

Erman Akkus, Medical Oncologist at Ankara University, shared a paper by Luke R.G. Pike et al. on…

All: 3 Posts: 1 - 100

Dr. Richard Pazdur: 25 Years of Transforming Oncology Drug Development at the FDA

New €4.9m Beaumont RCSI Cancer Centre and Irish Cancer Society Partnership to Transform Lung Cancer Care in Ireland

Biden Cancer Moonshot Initiative Awards Over $6 Million to 11 Early-Career Researchers for Innovative Cancer Research

Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More

Tom Green and Testicular Cancer: How He Went Against, How He Survived, and More

Special Coverage

ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023